Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

EpiGe: A cytosine methyl-genotyping PCR-based machine-learning tool for rapid classification of medulloblastoma

ABSTRACT: Molecular classification of medulloblastoma is critical for the correct treatment of this malignant paediatric brain tumour. The analysis of genome-wide DNA methylation patterns has profoundly improved diagnostic precision and classification of brain tumours. However, the implementation of DNA methylation microarrays in daily clinical practice can be time-consuming, costly and inaccessible for many centres worldwide. We aimed to develop a machine-learning decision support system for rapid and cost-effective prediction of medulloblastoma methylation class directly from quantitative PCR data.

ORGANISM(S): Homo sapiens

PROVIDER: GSE210723 | GEO | 2023/08/23

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

DNA methylation alterations across time and space in paediatric brain tumours

Project description:DNA methylation is increasingly used for tumour classification and has expanded upon the > 100 currently known brain tumour entities. A correct diagnosis is the basis for suitable treatment for patients with brain tumours, which is the leading cause of cancer-related death in children. DNA methylation profiling is required for diagnosis of certain tumours, and used clinically for paediatric brain tumours in several countries. We therefore evaluated if the methylation-based classification is robust in different locations of the same tumour, and determined how the methylation pattern changed over time to relapse.

2024-03-21 | GSE247880 | GEO

Epigenetic regulation of metabolic adaptation predicts response to Inositol hexakisphosphate (IP6) treatment in Group 4 medulloblastoma (HumanMethylation850)

Project description:Deregulation of chromatin modifiers plays an essential role in the pathogenesis of medulloblastoma (MB), the most common paediatric malignant brain tumour. Here, we identify a BMI1-dependent sensitivity to deregulation of inositol metabolism in a proportion of medulloblastoma. We demonstrate mTOR pathway activation and metabolic adaptation specifically in medulloblastoma of the molecular subgroup G4 characterised by a BMI1High;CHD7Low signature and show this can be counteracted by IP6 treatment. Finally, we demonstrate that IP6 synergises with cisplatin to enhance its cytotoxicity in vitro and extends survival in a pre-clinical BMI1High;CHD7Low xenograft model.

2021-03-04 | GSE155962 | GEO

Epigenetic regulation of metabolic adaptation predicts response to Inositol hexakisphosphate (IP6) treatment in Group 4 medulloblastoma (RNA-seq, ChIP-seq)

2021-03-04 | GSE154394 | GEO

Gene expression analysis of human medulloblastoma and neural stem cells

2014-10-23 | GSE62600 | GEO

Gene expression analysis of human medulloblastoma and neural stem cells

Project description:Medulloblastoma is the most common form of malignant paediatric brain tumour and is the leading cause of childhood cancer related mortality. The four molecular subgroups of medulloblastoma that have been identified M-bM-^@M-^S WNT, SHH, Group 3 and Group 4 - have molecular and topographical characteristics suggestive of different cells of origin. Definitive identification of the cell(s) of origin of the medulloblastoma subgroups, particularly the poorer prognosis Group 3 and Group 4 medulloblastoma, is critical to understand the pathogenesis of the disease, and ultimately for the development of more effective treatment options. The gene expression profiles of normal human neural tissues and cell types representing a broad neuro-developmental continuum, were compared to those of two independent cohorts of primary human medulloblastoma specimens. Total RNAwas extracted from 19 human primary medulloblastoma specimens, one human normal fetal brain (NFB) sample consisting of total RNA pooled from 50 individuals (embryonic week 22-33), two normal human fetal germinal matrix (NFGM) samples obtained from the lateral sub-ventricular zones of two 16 week old male fetuses, and CD133+ neural stem cells and CD133- neural progenitor cells isolated from embryonic stem cell derived neurospheres from three individuals. Gene expression profiling was carried out using Affymetrix U133A genechips.

2014-10-23 | E-GEOD-62600 | biostudies-arrayexpress

MB_xenograft_models

Project description:Classification of medulloblastoma xengrafts models primary human patient medulloblastoma samples were implanted into the corresponding position in SCID mice, the subsequent tumors gene expression profiles were compared with those of primary tumor samples to see if the overall transcriptomes were preserved. Repeat of each sample was the same labeled aRNA loaded onto another chip. Control samples include normal fetal brain, and normal adult cerebellum.

2012-04-04 | E-GEOD-28192 | biostudies-arrayexpress

A robust machine learning approach for missing persons cases with high genotyping errors

Project description:Estimating the relationships between individuals is one of the fundamental challenges in many fields. In particular, relationship estimation could provide valuable information for missing persons cases. The recently developed investigative genetic genealogy approach uses high-density single nucleotide polymorphisms (SNPs) to determine close and more distant relationships, in which hundreds of thousands to tens of millions of SNPs are generated either by microarray genotyping or whole-genome sequencing. The current studies usually assume the SNP profiles were generated with minimum errors. However, in the missing person cases, the DNA samples can be highly degraded, and the SNP profiles generated from these samples usually contain lots of errors. In this study, a robust machine learning approach was developed for estimating the relationships with high error SNP profiles. In this approach, a hierarchical classification strategy was employed first to classify the relationships by degree and then the relationship types within each degree separately. As for each classification, feature selection was implemented to gain better performance. Both simulated and real data sets with various genotyping error rates were utilized in evaluating this approach, and the accuracies of this approach were higher than individual measures; namely, this approach was more accurate and robust than the individual measures for SNP profiles with genotyping errors. In addition, the highest accuracy could be obtained by providing the same genotyping error rates in train and test sets, and thus estimating genotyping errors of the SNP profiles is critical to obtaining high accuracy of relationship estimation.

2022-07-27 | GSE209804 | GEO

The brain tumor classifications based on machine learning models trained with older version of methylation microarray chip compatible with the new EPIC v2 illumina’s chip.

Project description:Methylation profiling is a critical tool for brain tumor classification, and the Illumina methylation EPIC microarrays have been the dominant platform used for this purpose. The version 1 of the EPIC beadchips released in 2015 covers approximately 850k CpG sites, while version 2, released this year, has coverage over 950k CpG sites. Most probes on both chips overlap. However, the vendor has replaced over 15% of probes in v2 to address issues such as underlying SNPs, non-unique mapping, and off-target hybridization [1]. Moreover, EPIC v2 has over 200K additional new probes designed to enhance coverage of poorly covered genomic regions like enhancers and open chromatin regions. The EPICv2 lacks about 144k old probes present in the original content, comprising 16.5% of the old array content (Figure 1). If some of these missing probes were heavily used in predictors, they could potentially affect classifier results. The impact of changes in chip content on classifiers' predictions is uncertain. Herein, we validated the new methylation array to show that the new chip design does not affect tumor classification, although we found it may affect the classification score.

2023-09-01 | GSE229715 | GEO

Genotyping data from 49 patient with unexplained mental retardation

Project description:In the study we present a multicenter study in which three European diagnostic centres assessed the use of Affymetrix Mapping 500k SNP arrays for molecular karyotyping in patients with mental retardation. Each centre tested DNA from 40 patients with unexplained mental retardation together with their parents. In addition, 38 DNA samples containing known submicroscopic copy number variations (CNVs) were run for validation purposes.

2021-08-05 | GSE23557 | GEO

Genotyping data from 120 trios with unexplained mental retardation

2009-04-01 | GSE13117 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data